Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin
- PMID: 38753230
- PMCID: PMC11336000
- DOI: 10.1007/s11357-024-01176-2
Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin
Erratum in
-
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16‑hydroxyestriol, and late‑start canagliflozin.Geroscience. 2025 Aug;47(4):6093-6094. doi: 10.1007/s11357-024-01283-0. Geroscience. 2025. PMID: 39004654 Free PMC article. No abstract available.
-
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16-hydroxyestradiol, and late‑start canagliflozin.Geroscience. 2025 Oct;47(5):6663-6664. doi: 10.1007/s11357-025-01752-0. Geroscience. 2025. PMID: 40536755 Free PMC article. No abstract available.
Abstract
Genetically heterogeneous UM-HET3 mice born in 2020 were used to test possible lifespan effects of alpha-ketoglutarate (AKG), 2,4-dinitrophenol (DNP), hydralazine (HYD), nebivolol (NEBI), 16α-hydroxyestriol (OH_Est), and sodium thiosulfate (THIO), and to evaluate the effects of canagliflozin (Cana) when started at 16 months of age. OH_Est produced a 15% increase (p = 0.0001) in median lifespan in males but led to a significant (7%) decline in female lifespan. Cana, started at 16 months, also led to a significant increase (14%, p = 0.004) in males and a significant decline (6%, p = 0.03) in females. Cana given to mice at 6 months led, as in our previous study, to an increase in male lifespan without any change in female lifespan, suggesting that this agent may lead to female-specific late-life harm. We found that blood levels of Cana were approximately 20-fold higher in aged females than in young males, suggesting a possible mechanism for the sex-specific disparities in its effects. NEBI was also found to produce a female-specific decline (4%, p = 0.03) in lifespan. None of the other tested drugs provided a lifespan benefit in either sex. These data bring to 7 the list of ITP-tested drugs that induce at least a 10% lifespan increase in one or both sexes, add a fourth drug with demonstrated mid-life benefits on lifespan, and provide a testable hypothesis that might explain the sexual dimorphism in lifespan effects of the SGLT2 inhibitor Cana.
Keywords: Alpha-ketoglutarate; Lifespan; SGLT2 inhibitor Canagliflozin.
© 2024. The Author(s), under exclusive licence to American Aging Association.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Macchiarini F, Miller RA, Strong R, Rosenthal N, Harrison DE. NIA interventions testing program: a collaborative approach for investigating interventions to promote healthy aging. In: Musi N, Hornsby PJ, editors. Handbook of the Biology of Aging. 9th ed. London (UK): Academic Press; 2021.
-
- Harrison DE, Strong R, Reifsnyder P, Rosenthal N, Korstanje R, Fernandez E, et al. Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used. Geroscience. 2023;46(1):795–816. - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
